162
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy

, , , & ORCID Icon
Pages 525-537 | Published online: 22 Aug 2019

Figures & data

Figure 1 Decision tree.

Figure 1 Decision tree.

Figure 2 Model states.

Figure 2 Model states.

Table 1 Patient baseline characteristics

Table 2 Parameters for low response and non-adherence identification

Table 3 First year height SDS gain by age

Table 5 Drug usage

Table 6 Drug costs – base case

Table 7 Drug costs – scenario analysis

Table 8 Average height at full bone maturation – base case

Table 9 Average costs – base case

Table 10 Average height at full bone maturation – scenario analysis

Table 11 Average costs – scenario analysis